
Equity capital markets
Experts for all equity capital markets transactions with a team of specialist equity capital markets (ECM) lawyers, we provide strategic support, from startups to initial public offerings (IPOs), through to expanding market capitalisation via secondary fundraisings and advising on a range of capital management solutions
Alongside our capital markets services, our collaborative team leverages cross-disciplinary expertise across corporate advisory, tax and mergers and acquisitions.
As a dominant legal adviser in this market, the team has strong working relationships with issuers, shareholders, underwriters and regulators (ASX and ASIC) allowing a deep understanding of current market practice and trends.
From emerging start-ups to listed companies, we bring deep expertise across key growth industries, including resources and renewables, technology, life sciences, food and agribusiness, education, healthcare, financial services, and construction.
Initial public offerings
When advising on initial public offerings (IPOs), we combine technical precision with commercial pragmatism to deliver results that align with your strategic objectives and create lasting value.
Our comprehensive legal services cover the entire listing journey, from pre-IPO funding, structuring, due diligence, and regulatory approvals to prospectus preparation, investor engagement, and ASX exchange requirements.
Post-listing, we continue to support clients with ongoing compliance, corporate governance, secondary capital raisings and capital management solutions to ensure sustained market success.
Secondary raisings
Following a successful public listing, our specialist lawyers help clients navigate their capital needs for expanded growth. From implementing conventional to more complex convertible note and equity facilities, our support has enabled the successful delivery of milestone results for innovative, high-growth companies. We have also supported a range of cross-border capital raisings and dual listings.
Capital management
Our expertise extends to block trades and institutional selldowns, as well as capital management solutions such as buybacks, dividend reinvestment plans, special dividends, and capital reductions, as well as small-holding buybacks. Should the need arise, we can also assist with recapitalisation and relisting assignments, or orderly delisting.
Equity incentives
Working collaboratively with our expert colleagues, we are able to advise on the complexities of the Corporations Act, Listing Rules, taxation law and employment law to effectively implement equity incentives for executives and employees which are aligned to the company’s objectives. These might include share, option, or performance rights plans. Our experience also includes conforming foreign share plans to Australian legal requirements.
Start-ups, seed capital and venture capital
We understand the unique challenges of new and emerging businesses, which is why our team delivers tailored, commercial solutions to help navigate complexities and access the capital you need to transition from start-up to scale-up.
Our equity capital markets team expertly supports the capital needs of start-ups and unlisted companies, by facilitating venture capital and seed funding transactions, helping them secure the early-stage investment necessary for growth and development. We are familiar with the full range of structures used from Seed Capital to Series A funding and beyond, including SAFEs and other instruments.
For a trusted partner with decades of experience, contact Reece Walker.
Our legal expertise
Toys ‘R’ Us ANZ Limited (ASX: TOY)
Assisting Toys ‘R’ Us with a combination of private placements and short-term loan facilities, supporting the client with due diligence, preparation of offer materials, and verification of company documents.
Imugene Limited (ASX: IMU)
Assisted Imugene in raising up to $146 million to provide an extended runway for the company’s deep pipeline of clinical programs.
Radiopharm Theranostics (ASX: RAD)
Advised Radiopharm on its $20 million pre-IPO capital raising and subsequent $50 million IPO in December 2021. Assisted Radiopharm with $80+ million in secondary raises and a NASDAQ dual listing in November 2024.
Wagners Holding Company (ASX: WGN)
Advising on the third largest ASX listing of 2017 (market capitalisation of $437 million) for iconic construction group, Wagners. We advised on the IPO, as well as the restructuring of the group ahead of the IPO, and the demerger of the Wagners family shareholding (to occur following completion of the IPO).
Viralytics Limited
We advised on Viralytics Limited’s $502 million acquisition by Merck & Co Inc. by way of Scheme of Arrangement recognised as the “greatest sum ever offered for a local drug developer in the commercial history of Australian biotech”.
Over the Wire Holdings
Advising on a capital raising and double acquisition of Access Digital Networks and Comlinx. Led Over the Wire’s IPO and listing on the ASX in 2015 and its $390.4 million sale to Aussie Broadband Limited (by scheme of arrangement) in May 2022.
LGI Limited (ASX: LGI)
Advising on LGI’s IPO, valuing the company at $130 million and raising $25 million, to accelerate growth and expand its portfolio of biogas and energy projects to continue engineering a zero-carbon future.
XPON Technologies Group (ASX: XPN)
Advising on its $1.1 million pre-IPO capital raising and subsequent $12.5 million IPO in December 2021.
HRL Holdings Limited
Advising on its $82.2 million off-market takeover bid by global industrial, environmental and medical testing services company, ALS Limited (ASX: ALQ).
OneVue Holdings Limited
Advising OneVue Holdings Limited on its $115.2m sale to Iress Limited (by scheme of arrangement) in November 2020;
AVADA Group (ASX: AVD)
Advising on AVADA’s $32.5 million IPO in December 2021 and subsequent acquisitions of five complimentary businesses (Verifact Traffic, Arid to Oasis Traffic Solutions, Platinum Traffic Services, D&D Traffic Management and The Traffic Marshall).
Compono Pty Limited
Acting for Compono Pty Ltd on its dual track merger with Valti Pty Ltd and Future You Pty Ltd, together with a simultaneous capital raising;
Client results
Your equity capital markets team
Let us keep you across the latest developments